These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20546260)

  • 61. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
    Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
    Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group.
    Schiel R; Müller UA; Rauchfub J; Sprott H; Müller R
    Diabetes Metab; 1999 Sep; 25(4):334-40. PubMed ID: 10566123
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Initiating insulin therapy in patients with diabetes mellitus type 2: in a transmural setting is at least as effective as in an outpatient setting; a retrospective study with a 4-year follow-up].
    Rosendal H; Vondeling H; de Witte LP; Hutubessy RC; van Beekum WT; Heine RJ
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):166-71. PubMed ID: 11845567
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Barriers in initiating insulin therapy in a South Asian Muslim community.
    Ahmed US; Junaidi B; Ali AW; Akhter O; Salahuddin M; Akhter J
    Diabet Med; 2010 Feb; 27(2):169-74. PubMed ID: 20546260
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Barriers to insulin initiation and intensification and how to overcome them.
    Kunt T; Snoek FJ
    Int J Clin Pract Suppl; 2009 Oct; (164):6-10. PubMed ID: 19751453
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient.
    Meneghini L
    Int J Clin Pract; 2008 Aug; 62(8):1255-64. PubMed ID: 18705822
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Addressing barriers to initiation of insulin in patients with type 2 diabetes.
    Peyrot M; Rubin RR; Khunti K
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S11-8. PubMed ID: 20394886
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of barriers to insulin therapy and approaches to overcoming them.
    Russell-Jones D; Pouwer F; Khunti K
    Diabetes Obes Metab; 2018 Mar; 20(3):488-496. PubMed ID: 29053215
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.